1. Leaving a Trial Before Its End It is important for prostate cancer patients to understand the implications of being a volunteer in a clinical trial before deciding to participate in it. This also includes considering what happens after the end of the clinical trial. Every participant has the right to leave a clinical trial at any time and for any reason. However, the treatment may be compromised if a patient leaves the study earlier. If the patient is determined to leave the clinical trial before the planned end, it is important to discuss with the study team and physician if it is safe to stop the treatment or trading it for other regimens, if the health records from the study will be transferred to the participant’s physician, how care will continue to be paid for after the participant leaves the study, and what treatment the participant will have after leaving the study.